1. Sociedad Española de Retina y Vítreo (SERV). Consenso SERV sobre degeneración macular asociada a la edad (DMAE). Disponible en: https://serv.es/wp-content/descargasWP/documentacionMedica/consenso_DMAE.pdf
2. Lim JI, et al. Systematic review of clinical practice guidelines for the management of neovascular age-related macular degeneration. Eye. 2025;39:2223–2230.
3. Fleckenstein M et al. Age-Related Macular Degeneration: A Review. JAMA Ophthalmology (2024).
4. Guymer RH, et al. Age-related macular degeneration: global prevalence update. ScienceDirect (review). 2023
5. Jonasson F., et al. Prevalence of Age-related Macular Degeneration in Old Persons. Age, Gene/Environment Susceptibility Reykjavik Study. Ophthalmology. 2010 Dec 3;118(5):825–830.
6. Wong W.L., et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.Lancet Glob Health 2014 Feb;2(2):e106-16.
7. Ferris FL, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844-51
8. Tian M, Zhang B. et al. Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies. Front Med (Lausanne). 2025;12:1544765.